Table 4 Phenotype frequencies of HLA-ABDR alleles according to latency period

A1

5 (11.0%)

4 (8.0%)

NS*

A2

11 (24.0%)

11 (22.0%)

NS*

A3

4 (8.7%)

3 (6.0%)

NS*

A11

8 (17.4%)

8 (16.0%)

NS*

A23

1 (2.2%)

2 (4.0%)

NS*

A24

8 (17.4%)

15 (30.0%)

NS*

A26

2 (4.4%)

2 (4.0%)

NS*

A29

2 (4.4%)

1 (2.0%)

NS*

A30

4 (8.7%)

1 (2.0%)

NS*

A32

0 (0.0%)

2 (4.0%)

NS*

A33

1 (2.2%)

0 (0.0%)

NS*

A68

0 (0.0%)

1 (2.0%)

NS*

B7

3 (6.6%)

5 (10.0%)

NS*

B8

1 (2.2%)

2 (4.0%)

NS*

B13

3 (6.6%)

0 (0.0%)

NS*

B18

2 (4.4%)

1 (2.0%)

NS*

B27

1 (2.2%)

0 (0.0%)

NS*

B35

15 (32.7%)

15 (30.0%)

NS*

B37

1 (2.2%)

1 (2.0%)

NS*

B38

1 (2.2%)

0 (0.0%)

NS*

B39

1 (2.2%)

1 (2.0%)

NS*

B40

1 (2.2%)

3 (6.0%)

NS*

B41

2 (4.4%)

0 (0.0%)

NS*

B44

2 (4.4%)

2 (4.0%)

NS*

B49

2 (4.4%)

1 (2.0%)

NS*

B50

1 (2.2%)

1 (2.0%)

NS*

B51

8 (17.4%)

6 (12.0%)

NS*

B52

0 (0.0%)

3 (6.0%)

NS*

B54

0 (0.0%)

1 (2.0%)

NS*

B55

2 (4.4%)

3 (6.0%)

NS*

B57

2 (4.4%)

2 (4.0%)

NS*

B64

0 (0.0%)

1 (2.0%)

NS*

DR3

1 (2.2%)

5 (10.0%)

NS*

DR4

4 (8.7%)

8 (16.0%)

NS*

DR7

6 (13.1%)

2 (4.0%)

NS*

DR10

2 (4.4%)

2 (4.0%)

NS*

DR11

12 (26.2%)

11 (22.0%)

NS*

DR13

6 (13.1%)

5 (10.0%)

NS*

DR14

6 (13.1%)

5 (10.0%)

NS*

DR15

5 (11%)

9 (18.0%)

NS*

DR16

2 (4.4%)

5 (10.0%)

NS*